StockPriceToday

Bruker Corporation (BRKR)

BRKR stock price

Bruker Corporation manufactures scientific instruments for molecular and materials research, industrial applications, and clinical diagnostics.

About Bruker Corporation

Bruker Corporation operates as a manufacturer of scientific instruments and solutions for molecular and materials research, industrial applications, and clinical diagnostics serving customers worldwide. The company's scientific instrument focus makes BRKR stock price sensitive to research and development spending trends, academic funding levels, and analytical instrument market demand.

The company's product portfolio includes mass spectrometry, magnetic resonance, X-ray, and other analytical instruments used in pharmaceutical research, materials science, clinical diagnostics, and academic research. Bruker's technology enables advanced scientific analysis and discovery across various fields.

BRKR stock price benefits from increasing research and development activity, growing demand for analytical instrumentation, and expanding applications requiring advanced scientific analysis capabilities. The company's diverse end markets provide stability across different research sectors and economic conditions.

Bruker Corporation's focus on innovation and customer collaboration positions the company to compete effectively in the evolving scientific instrumentation market. The company's technical expertise and global presence support BRKR stock price growth potential as scientific research becomes increasingly sophisticated and requires advanced analytical capabilities across pharmaceutical, academic, and industrial applications.

BRKR Stock 12 Month Chart


Latest News for BRKR

What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR). jumped 4% in the afternoon session after the company announced new Nuclear Magnetic Resonance (NMR) products and workflow ...

On April 6, 2026, Bruker Corporation and Falko Busse, Ph.D., President of its Bruker BioSpin Group, agreed that his executive duties would begin transitioning around May 1, 2026, with his employment ...

BRKR faces macro and currency headwinds, but strong BSI Nano growth, AI-driven demand and BioSpin innovations support its long-term outlook.